Good ideas and conversation. No ads, no tracking. Login or Take a Tour!
It's the $40 billion drug market that no company wants a part of. As resistance to antibiotics allows long-treatable diseases to once again become killers, pharmaceutical companies are sacking their antibiotic researchers. Keri Phillips reports.